Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2010, Article ID 138758, 7 pages
http://dx.doi.org/10.1155/2010/138758
Research Article

Expression of Chemoresistance-Related Genes and Heat Shock Protein 72 in Hyperthermic Isolated Limb Perfusion of Malignant Melanoma: An Experimental Study

1Department of Surgery, University of Erlangen-Nürnberg, 91054 Erlangen, Germany
2Department of Surgery, Klinikum Ansbach, Germany

Received 18 January 2010; Accepted 12 May 2010

Academic Editor: Dominic Fan

Copyright © 2010 C. Knorr et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Meyer, J. Göhl, O. Schmidt et al., “Preclinical studies concerning hyperthermic isolated limb perfusion (HILP) of malignant melanoma,” Regional Cancer Treatment, vol. 7, no. 3-4, pp. 138–143, 1994. View at Google Scholar · View at Scopus
  2. T. Meyer, J. Göhl, C. Haas, and W. Hohenberger, “Hyperthermic isolated limb perfusion—23 years' experience and improvement of results by modification of technique,” Onkologie, vol. 21, no. 3, pp. 198–202, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Knorr, T. Meyer, T. Janssen, J. Goehl, and W. Hohenberger, “Hyperthermic isolated limb perfusion (HILP) in malignant melanoma. Experience with 101 patients,” European Journal of Surgical Oncology, vol. 32, no. 2, pp. 224–227, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. C. E. Boesch, T. Meyer, and L. Waschke, “Long-term outcome of hyperthermic isolated limb perfusion (HILP) in the treatment of locoregionally metastasized malignant melanoma of the extremities,” International Journal of Hyperthermia, vol. 26, no. 1, pp. 16–20, 2010. View at Google Scholar
  5. D.-W. Shen, A. Fojo, and J. E. Chin, “Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification,” Science, vol. 232, no. 4750, pp. 643–645, 1986. View at Google Scholar · View at Scopus
  6. S. Van der Heyden, E. Gheuens, E. De Bruijn, A. Van Oosterom, and R. Maes, “P-glycoprotein: clinical significance and methods of analysis,” Critical Reviews in Clinical Laboratory Sciences, vol. 32, no. 3, pp. 221–264, 1995. View at Google Scholar · View at Scopus
  7. D. Keppler, I. Leier, G. Jedlitschky, and J. König, “ATP-dependent transport of glutathione S-conjugates by the multidrug resistance protein MRP1 and its apical isoform MRP2,” Chemico-Biological Interactions, vol. 111-112, pp. 153–161, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. P. G. Komarov, A. A. Shtil, O. Holian et al., “Activation of the LRP (Lung Resistance-Related Protein) gene by short-term exposure of human leukemia cells to phorbol ester and cytarabine,” Oncology Research, vol. 10, no. 4, pp. 185–192, 1998. View at Google Scholar · View at Scopus
  9. N. F. Fanning and H. P. Redmond, “Heat shock proteins in the regulation of the apoptotic response,” Sepsis, vol. 2, no. 1, pp. 47–53, 1998. View at Google Scholar · View at Scopus
  10. A. J. L. Macario, “Heat-shock proteins and molecular chaperones: implications for pathogenesis, diagnostics, and therapeutics,” International Journal of Clinical and Laboratory Research, vol. 25, no. 2, pp. 59–70, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. S.-N. C. Liossis, X. Z. Ding, J. G. Kiang, and G. C. Tsokos, “Overexpression of the heat shock protein 70 enhances the TCR/CD3- and Fas/Apo-1/CD95-mediated apoptotic cell death in Jurkat T cells,” Journal of Immunology, vol. 158, no. 12, pp. 5668–5675, 1997. View at Google Scholar · View at Scopus
  12. T. Meyer, J. Göhl, W. Hohenberger, and H. Schönenberger, “Investigations regarding the choice of the cytostatic agent in hyperthermic isolated limb perfusion (HILP): chemosensitivity testing on 5 human melanoma cell lines,” Melanoma Research, vol. 3, supplement 1, pp. 98–99, 1993. View at Google Scholar
  13. K. Nagel, F. Ghussen, I. Kruger, and W. Isselhard, “Miniature equipment for the perfusion of rat limbs,” Research in Experimental Medicine, vol. 187, no. 1, pp. 1–8, 1987. View at Google Scholar · View at Scopus
  14. W. Tilgen, “Malignant melanoma: current therapeutic concepts,” Onkologie, vol. 18, no. 6, pp. 534–547, 1995. View at Google Scholar · View at Scopus
  15. B. Fuchs, H. Ostmeier, and L. Suter, “P-glycoprotein expression in malignant melanoma,” Journal of Cancer Research and Clinical Oncology, vol. 117, no. 2, pp. 168–171, 1991. View at Google Scholar · View at Scopus
  16. D. Schadendorf, A. Makki, C. Stahr et al., “Membrane transport proteins associated with drug resistance expressed in human melanoma,” American Journal of Pathology, vol. 147, no. 6, pp. 1545–1552, 1995. View at Google Scholar · View at Scopus
  17. D. Schadendorf, R. Herfordt, and B. M. Czarnetzki, “P-glycoprotein expression in primary and metastatic malignant melanoma,” British Journal of Dermatology, vol. 132, no. 4, pp. 551–555, 1995. View at Google Scholar · View at Scopus
  18. S. Labialle, G. Dayan, J. Gambrelle et al., “Characterization of the typical multidrug resistance profile in human uveal melanoma cell lines and in mouse liver metastasis derivatives,” Melanoma Research, vol. 15, no. 4, pp. 257–266, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. A.-L. Cheng, I.-J. Su, Y.-C. Chen, T.-C. Lee, and C.-H. Wang, “Expression of P-glycoprotein and glutathione-S-transferase in recurrent lymphomas: the possible role of Epstein-Barr virus, immunophenotypes, and other predisposing factors,” Journal of Clinical Oncology, vol. 11, no. 1, pp. 109–115, 1993. View at Google Scholar · View at Scopus
  20. C. Rodriguez, T. Commes, J. Robert, and J.-F. Rossi, “Expression of P-glycoprotein and anionic glutathione S-transferase genes in non-Hodgkin's lymphoma,” Leukemia Research, vol. 17, no. 2, pp. 149–156, 1993. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Licht, “Pleiotrope zytostatikaresistenz (multidrug resistance) und hochdosischemotherapie,” in Handbuch der Molekularen Medizin, Band 2, Tumorerkrankungen, D. Ganten and K. Ruckpaul, Eds., pp. 65–87, Springer, Berlin, Germany, 1998. View at Google Scholar
  22. T. Meyer, R. Greim, J. Göhl, and W. Hohenberger, “Mechanisms of resistance in hyperthermic isolated limb perfusion (HILP) of regionally metastasized malignant melanoma. Expression of chemoresistance genes under clinical conditions,” Langenbeck's Archives of Surgery, vol. 384, p. 508, 1999. View at Google Scholar
  23. P. Sonneveld, B. G.M. Durie, H. M. Lokhorst et al., “Modulation of multidrug-resistant multiple myeloma by cyclosporin,” Lancet, vol. 340, no. 8814, pp. 255–259, 1992. View at Publisher · View at Google Scholar · View at Scopus
  24. W. H. Wilson, C. Jamis-Dow, G. Bryant et al., “Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy,” Journal of Clinical Oncology, vol. 13, no. 8, pp. 1985–1994, 1995. View at Google Scholar · View at Scopus
  25. S. Oesterreich, C.-N. Weng, M. Qiu, S. G. Hilsenbeck, C. K. Osborne, and S. A. W. Fuqua, “The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines,” Cancer Research, vol. 53, no. 18, pp. 4443–4448, 1993. View at Google Scholar · View at Scopus
  26. E. H. Richards, E. Hickey, L. Weber, and J. R. W. Masters, “Effect of overexpression of the small heat shock protein HSP27 on the heat and drug sensitivities of human testis tumor cells,” Cancer Research, vol. 56, no. 10, pp. 2446–2451, 1996. View at Google Scholar · View at Scopus
  27. G. Sliutz, J. Karlseder, C. Tempfer, L. Orel, G. Holzer, and M. M. Simon, “Drug resistance against gemcitabine and topotecan mediated by constitutive hsp70 overexpression in vitro: implication of quercetin as sensitiser in chemotherapy,” British Journal of Cancer, vol. 74, no. 2, pp. 172–177, 1996. View at Google Scholar · View at Scopus
  28. K.-V. Chin, S. Tanaka, G. Darlington, I. Pastan, and M. M. Gottesman, “Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells,” Journal of Biological Chemistry, vol. 265, no. 1, pp. 221–226, 1990. View at Google Scholar · View at Scopus
  29. K.-V. Chin, K. Ueda, I. Pastan, and M. M. Gottesman, “Modulation of activity of the promoter of the human MDR1 gene by Ras and p53,” Science, vol. 255, no. 5043, pp. 459–462, 1992. View at Google Scholar · View at Scopus
  30. N. Kioka, Y. Yamano, T. Komano, and K. Ueda, “Heat-shock responsive elements in the induction of the multidrig resistance gene (MDR1),” FEBS Letters, vol. 301, no. 1, pp. 37–40, 1992. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Delpino, R. Falcioni, and U. Ferrini, “Modulation of heat shock protein synthesis in two human melanoma cell lines,” Tumori, vol. 70, no. 5, pp. 393–398, 1984. View at Google Scholar · View at Scopus
  32. A. Delpino, A. M. Mileo, E. Mattei, and U. Ferrini, “Characterization of the heat shock response in M-14 human melanoma cells continuously exposed to supranormal temperatures,” Experimental and Molecular Pathology, vol. 45, no. 2, pp. 128–141, 1986. View at Google Scholar · View at Scopus
  33. T. Muramatsu, N. Kobayashi, H. Tada, M. Hatoko, and T. Shirai, “Induction of the 72-kD heat shock protein in human skin melanoma and squamous cell carcinoma cell lines,” Journal of Dermatology, vol. 22, no. 12, pp. 907–912, 1995. View at Google Scholar · View at Scopus
  34. J. A. Krewet, W. Ren, X. F. Huang, S.-Y. Chen, and M. R. Shah, “Anti-tumor immune responses following neoadjuvant immunotherapy with a recombinant adenovirus expressing HSP72 to rodent tumors,” Cancer Immunology, Immunotherapy, vol. 54, no. 10, pp. 988–998, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. M. P. Protti, S. Heltai, M. Bellone, M. Ferrarini, A. A. Manfredi, and C. Rugarli, “Constitutive expression of the heat shock protein 72 kDa in human melanoma cells,” Cancer Letters, vol. 85, no. 2, pp. 211–216, 1994. View at Publisher · View at Google Scholar · View at Scopus
  36. A. C. Lazaris, G. E. Theodoropoulos, K. Aroni, A. Saetta, and P. S. Davaris, “Immunohistochemical expression of C-myc oncogene, heat shock protein 70 and HLA-DR molecules in malignant cutaneous melanoma,” Virchows Archiv, vol. 426, no. 5, pp. 461–467, 1995. View at Google Scholar · View at Scopus
  37. P. R. Wachsberger, J. Landry, C. Storck et al., “Mammalian cells adapted to growth at pH 6.7 have elevated HSP27 levels and are resistant to cisplatin,” International Journal of Hyperthermia, vol. 13, no. 3, pp. 251–259, 1997. View at Google Scholar · View at Scopus
  38. R. I. Morimoto, “Cells in stress: transcriptional activation of heat shock genes,” Science, vol. 259, no. 5100, pp. 1409–1410, 1993. View at Google Scholar · View at Scopus
  39. J. Göhl, Th. Meyer, W. Hohenberger, and U. Loos, “An experimental animal study for optimizing treatment modalities in isolation perfusion,” Melanoma Research, vol. 3, supplement 1, p. 98, 1993. View at Google Scholar
  40. J. Pelz, M. Mollwitz, C. Stremmel et al., “The impact of surgery and mild hyperthermia on tumor response and angioneogenesis of malignant melanoma in a rat perfusion model,” BMC Cancer, vol. 4, article 53, 2004. View at Publisher · View at Google Scholar · View at Scopus